Similar articles

• Treatment of multiple sclerosis and other autoimmune diseases with cladribine.

  Beutler E, Sipe J, Romine J, McMillan R, Zyroff J, Koziol J. Beutler E, et al. Semin Hematol. 1996 Jan;33(1 Suppl 1):45-52. Semin Hematol. 1996. PMID: 8714617 Clinical Trial. No abstract available.
• [Interferon-beta in treatment of relapsing multiple sclerosis].

  Hartung HP, Hohlfeld R. Hartung HP, et al. Nervenarzt. 1994 Feb;65(2):139-45. Nervenarzt. 1994. PMID: 8164769 Clinical Trial. German. No abstract available.
• [Oral, low-dosage methotrexate in chronic progressive multiple sclerosis. A preliminary critical analysis].

  Weilbach FX, Toyka KV, Hartung HP. Weilbach FX, et al. Nervenarzt. 1995 Aug;66(8):643-7. Nervenarzt. 1995. PMID: 7566279 Clinical Trial. German. No abstract available.
• [Current therapy of multiple sclerosis: mitoxantrone].

  Spuler S, Hohlfeld R. Spuler S, et al. Nervenarzt. 1994 Feb;65(2):136-8. Nervenarzt. 1994. PMID: 8164768 Review. German. No abstract available.
• [Guidelines for drug treatment of multiple sclerosis].

  Kollegger H, Vass K, Marschall I, Koch G, Deecke L. Kollegger H, et al. Wien Klin Wochenschr. 1993;105(16):443-52. Wien Klin Wochenschr. 1993. PMID: 7692677 Review. German.